Works matching IS 11727047 AND DT 2023 AND VI 37 AND IP 3

Results: 8

Correction to: Daridorexant in Insomnia Disorder: A Profile of Its Use.
Published in:
2023
By:
- Nie, Tina;
- Blair, Hannah A.
Publication type:
Correction Notice
Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials.
Published in:
CNS Drugs, 2023, v. 37, n. 3, p. 215, doi. 10.1007/s40263-023-00993-x
By:
- Arteaga-Henríquez, Gara;
- Gisbert, Laura;
- Ramos-Quiroga, Josep Antoni
Publication type:
Article
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Novel Recombination Human Nerve Growth Factor in Healthy Chinese Subjects.
Published in:
CNS Drugs, 2023, v. 37, n. 3, p. 231, doi. 10.1007/s40263-023-00991-z
By:
- Shen, Qi;
- Zhang, Mengyu;
- Jin, Ying;
- Di, Xiangjie;
- Liu, Runhan;
- Wang, Zhenlei
Publication type:
Article
Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment.
Published in:
CNS Drugs, 2023, v. 37, n. 3, p. 203, doi. 10.1007/s40263-023-00990-0
By:
- Goldstein, Rachel;
- Jacobs, Aviya R.;
- Zighan, Lana;
- Gronich, Naomi;
- Bialer, Meir;
- Muszkat, Mordechai
Publication type:
Article
Cytokine- and Vascular Endothelial Growth Factor-Related Gene-Based Genome-Wide Association Study of Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression.
Published in:
CNS Drugs, 2023, v. 37, n. 3, p. 243, doi. 10.1007/s40263-023-00989-7
By:
- Tsai, Shih-Jen;
- Kao, Chung-Feng;
- Su, Tung-Ping;
- Li, Cheng-Ta;
- Lin, Wei-Chen;
- Hong, Chen-Jee;
- Bai, Ya-Mei;
- Tu, Pei-Chi;
- Chen, Mu-Hong
Publication type:
Article
Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine.
Published in:
CNS Drugs, 2023, v. 37, n. 3, p. 255, doi. 10.1007/s40263-023-00988-8
By:
- Blair, Hannah A.
Publication type:
Article
Daridorexant in Insomnia Disorder: A Profile of Its Use.
Published in:
CNS Drugs, 2023, v. 37, n. 3, p. 267, doi. 10.1007/s40263-023-00987-9
By:
- Nie, Tina;
- Blair, Hannah A.
Publication type:
Article
Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label Study
Published in:
CNS Drugs, 2023, v. 37, n. 3, p. 275, doi. 10.1007/s40263-022-00982-6
By:
- Perumal, Jai;
- Balabanov, Roumen;
- Su, Ray;
- Chang, Roger;
- Balcer, Laura J.;
- Galetta, Steven L.;
- Avila, Robin L.;
- Rutledge, Danette;
- Fox, Robert J.
Publication type:
Article